cysteine has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, P; Pal, A; Pal, BB; Rao, GN | 1 |
| Baker, NL; Bielawski, J; El Abiad, JM; Hammad, SM; Klein, RL; Lopes-Virella, MF; Pierce, JS; Rembiesa, B; Spassieva, SD | 1 |
2 other study(ies) available for cysteine and Diabetic Neuropathies
| Article | Year |
|---|---|
Hyperglycemia-induced oxidative stress induces apoptosis by inhibiting PI3-kinase/Akt and ERK1/2 MAPK mediated signaling pathway causing downregulation of 8-oxoG-DNA glycosylase levels in glial cells.
Topics: Animals; Apoptosis; Cysteine; Diabetic Neuropathies; DNA Glycosylases; Glucose; Humans; Hyperglycemia; Lipid Peroxidation; Mitogen-Activated Protein Kinase Kinases; Neuroglia; Oncogene Protein v-akt; Oxidative Stress; Phosphatidylinositol 3-Kinases; Rats; Signal Transduction | 2014 |
Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot Study.
Topics: Adult; Amino Acids; Ceramides; Cross-Sectional Studies; Cysteine; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Follow-Up Studies; Glycosphingolipids; Humans; Male; Observational Studies as Topic; Odds Ratio; Pilot Projects; Sensation Disorders; Sphingolipids; Sphingomyelins; Tandem Mass Spectrometry; Young Adult | 2017 |